BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23762367)

  • 21. Yield of Facility-based Targeted Universal Testing for Tuberculosis With Xpert and Mycobacterial Culture in High-Risk Groups Attending Primary Care Facilities in South Africa.
    Berhanu RH; Lebina L; Nonyane BAS; Milovanovic M; Kinghorn A; Connell L; Nyathi S; Young K; Hausler H; Naidoo P; Brey Z; Shearer K; Genade L; Martinson NA
    Clin Infect Dis; 2023 May; 76(9):1594-1603. PubMed ID: 36610730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid urine-based screening tests increase the yield of same-day tuberculosis diagnoses among patients living with advanced HIV disease.
    Wake RM; Govender NP; Omar SV; Ismail F; Tiemessen CT; Harrison TS; Jarvis JN
    AIDS; 2022 May; 36(6):839-844. PubMed ID: 35075041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility of repeat Xpert MTB/RIF testing to diagnose tuberculosis in HIV-positive adults with initial negative result.
    Hanifa Y; Fielding KL; Chihota VN; Adonis L; Charalambous S; Foster N; Karstaedt A; McCarthy K; Nicol MP; Ndlovu NT; Sinanovic E; Sahid F; Stevens W; Vassall A; Churchyard GJ; Grant AD
    Gates Open Res; 2018; 2():22. PubMed ID: 37700854
    [No Abstract]   [Full Text] [Related]  

  • 24. Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa.
    Brust JC; Lygizos M; Chaiyachati K; Scott M; van der Merwe TL; Moll AP; Li X; Loveday M; Bamber SA; Lalloo UG; Friedland GH; Shah NS; Gandhi NR
    PLoS One; 2011 Jan; 6(1):e15841. PubMed ID: 21253585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe.
    Macpherson P; Dimairo M; Bandason T; Zezai A; Munyati SS; Butterworth AE; Mungofa S; Rusakaniko S; Fielding K; Mason PR; Corbett EL
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1390-6. PubMed ID: 22283900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.
    Brust JC; Shah NS; Scott M; Chaiyachati K; Lygizos M; van der Merwe TL; Bamber S; Radebe Z; Loveday M; Moll AP; Margot B; Lalloo UG; Friedland GH; Gandhi NR
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):998-1004. PubMed ID: 22668560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insufficient tuberculosis treatment leads to earlier and higher mortality in individuals co-infected with HIV in southern China: a cohort study.
    Zheng Z; Nehl EJ; Zhou C; Li J; Xie Z; Zhou Z; Liang H
    BMC Infect Dis; 2020 Nov; 20(1):873. PubMed ID: 33225919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling the impact of universal tuberculosis molecular testing and timing of tuberculosis preventive treatment during antiretroviral therapy initiation in South Africa.
    Balasubramanian R; Shearer K; Mudzengi D; Hippner P; Golub JE; Chihota V; Hoffmann CJ; Kendall EA
    AIDS; 2023 Dec; 37(15):2371-2379. PubMed ID: 37650763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the GeneXpert MTB/RIF Technology on Tuberculosis Control.
    Stevens WS; Scott L; Noble L; Gous N; Dheda K
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28155817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda.
    Zawedde-Muyanja S; Katamba A; Cattamanchi A; Castelnuovo B; Manabe YC
    BMC Public Health; 2020 Dec; 20(1):1855. PubMed ID: 33272226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of point-of-care C-reactive protein testing for screening of tuberculosis in the community in high-burden settings: a prospective, cross-sectional study in Zambia and South Africa.
    Ruperez M; Shanaube K; Mureithi L; Wapamesa C; Burnett MJ; Kosloff B; de Haas P; Hayes R; Fidler S; Gachie T; Schaap A; Floyd S; Klinkenberg E; Ayles H;
    Lancet Glob Health; 2023 May; 11(5):e704-e714. PubMed ID: 37061309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant TB patients in Khayelitsha, South Africa.
    Mohr E; Cox V; Wilkinson L; Moyo S; Hughes J; Daniels J; Muller O; Cox H
    Trans R Soc Trop Med Hyg; 2015 Jul; 109(7):425-32. PubMed ID: 25979526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioaerosol sampling of patients with suspected pulmonary tuberculosis: a study protocol.
    Patterson B; Koch A; Gessner S; Dinkele R; Gqada M; Bryden W; Cobelens F; Little F; Warner DF; Wood R
    BMC Infect Dis; 2020 Aug; 20(1):587. PubMed ID: 32770954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India.
    Isaakidis P; Paryani R; Khan S; Mansoor H; Manglani M; Valiyakath A; Saranchuk P; Furin J
    PLoS One; 2013; 8(7):e68869. PubMed ID: 23894358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A blood-based 3-gene signature score for therapeutic monitoring in patients with pulmonary tuberculosis.
    Zhang P; Zheng J; Han T; Ma J; Gnanashanmugam D; Li M; Tang YW; Deng G
    Tuberculosis (Edinb); 2024 Jul; 147():102521. PubMed ID: 38801793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculosis pharmacotherapy: strategies to optimize patient care.
    Mitnick CD; McGee B; Peloquin CA
    Expert Opin Pharmacother; 2009 Feb; 10(3):381-401. PubMed ID: 19191677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory microbes present in the nasopharynx of children hospitalised with suspected pulmonary tuberculosis in Cape Town, South Africa.
    Dube FS; Kaba M; Robberts FJ; Ah Tow L; Lubbe S; Zar HJ; Nicol MP
    BMC Infect Dis; 2016 Oct; 16(1):597. PubMed ID: 27776489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis.
    Denti P; Garcia-Prats AJ; Draper HR; Wiesner L; Winckler J; Thee S; Dooley KE; Savic RM; McIlleron HM; Schaaf HS; Hesseling AC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensified pulmonary tuberculosis case finding among HIV-infected new entrants of a prison in Malaysia: implications for a holistic approach to control tuberculosis in prisons.
    Al-Darraji H; Hill P; Sharples K; Altice FL; Kamarulzaman A
    Int J Prison Health; 2023 Jan; ():. PubMed ID: 36622107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for tuberculosis-related death among adults with drug-sensitive pulmonary tuberculosis in Selangor, Malaysia from 2013 to 2019: a retrospective cohort study using surveillance data.
    Suhairi MH; Mohamad M; Isa MR; Mohd Yusoff MAS; Ismail N
    BMJ Open; 2024 Feb; 14(2):e080144. PubMed ID: 38413152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.